326495-42-5

326495-42-5 structure

Name: (2R)-3-{[(2-Aminoethoxy)(hydroxy)phosphoryl]oxy}-2-[(2H31)hexadecanoyloxy]propyl (2H31)hexadecanoate
Chemical Name: (2R)-3-{[(2-Aminoethoxy)(hydroxy)phosphoryl]oxy}-2-[(2H31)hexadecanoyloxy]propyl (2H31)hexadecanoate
CAS Number: 326495-42-5
Molecular Formula: C₃₇H₁₂D₆₂NO₈P
Molecular Weight: 754.341
Catalog: Research Areas Metabolic Disease
Create Date: 2018-05-24 07:39:10
Modify Date: 2024-01-09 12:51:49
1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-d62 is deuterium labeled 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine. 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine is an endogenous metabolite.

Name	(2R)-3-{[(2-Aminoethoxy)(hydroxy)phosphoryl]oxy}-2-[(2H31)hexadecanoyloxy]propyl (2H31)hexadecanoate
Synonyms	Hexadecanoic-d acid, (1R)-1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester (2R)-3-{[(2-Aminoethoxy)(hydroxy)phosphoryl]oxy}-2-[(H)hexadecanoyloxy]propyl (H)hexadecanoate

Description	1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine-d62 is deuterium labeled 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine. 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine is an endogenous metabolite.
Related Catalog	Research Areas >> Metabolic Disease
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[2].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223.